Navigation Links
Beekeepers, Researchers and Bayer CropScience Associate Overwintering Bee Losses with Varroa Mite
Date:4/2/2013

RESEARCH TRIANGLE PARK, N.C. (PRWEB) April 02, 2013

Honey bees are essential to the world’s agricultural system and food supply. More than a quarter of the food produced in the U.S. is dependent upon honey bees because of their efficiency and utility as pollinators. Although colony losses are typically expected following the winter season, experts have expressed concerns about the severity of this winter‘s colony losses.

University and government scientists, beekeepers and other bee experts attributed this year’s possible higher losses to an increased presence of Varroa mites. The Varroa mite is a parasite that feeds on the blood of honey bees and reproduces on the developing bee brood. An increased Varroa mite infestation weakens bees and could lead to a devastating colony loss during the stressful wintering period. Overwintering losses are not discernable until the following spring.

Bayer Crop Science recently developed a research brief and video on overwintering losses as part of Bayer’s Bee Care Program in order to inform and educate beekeepers, farmers and others interested in engaging in the conversation on bee health. Bayer has established one Bee Care Center dedicated to improving the understanding and health of pollinators, located in Monheim, Germany, and is currently building another Center in Research Triangle Park, N.C. The Bayer Bee Care Centers, an essential element in the Program, will host research focused on integrated management of the mul
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
2. In new quantum-dot LED design, researchers turn troublesome molecules to their advantage
3. Multidisciplinary team of researchers develop world’s lightest material
4. Researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment
5. Innovative MetaMorph® NX Software Shatters Barriers Between Researchers and Image Analysis Goals with Exclusive Visual Workflow
6. UCLA researchers demonstrate fully printed carbon nanotube transistor circuits for displays
7. Penn and Brown researchers demonstrate earthquake friction effect at the nanoscale
8. Two Top Biological Imaging Centers Offer Powerful Free Online Tool to Researchers, Educators, and Public
9. Researchers develop one of the worlds smallest electronic circuits
10. MU researchers identify key plant immune response in fight against bacteria
11. Researchers realize high-power, narrowband terahertz source at room temperature
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... July 28, 2015  Kerastem Technologies announce that the ... U.S. FDA Center For Biologics Evaluation and Research (CBER) ... a clinical trial investigating the safety and feasibility of ... early male pattern baldness (androgenic alopecia). The ... initial clinical work in Europe ...
(Date:7/28/2015)... , July 28, 2015 CSL Behring ... Administration has accepted for review the company,s Biologics License ... single-chain (rVIII-SingleChain) for the treatment of hemophilia A. In ... Hemophilia A is a ... VIII; nearly all affected patients are male. People with ...
(Date:7/28/2015)... ZIONA, Israel , July 28, ... OTC:CQPTY), a regenerative medicine company utilizing its proprietary ... announced that Shomrat Shurtz has been appointed Senior ...      (Photo: http://photos.prnewswire.com/prnh/20150728/246955 ) ... years of experience in marketing, regulatory and business ...
(Date:7/27/2015)... FRANKLIN, Tenn. , July 27, ... provider of health care services and one of ... today announced that its parent company and sole ... agreement with Medical Properties Trust, Inc. ("MPT") (NYSE: ... for $900 million in cash.  The transaction is expected to ...
Breaking Biology Technology:Kerastem Receives Conditional Approval from FDA for Alopecia Trial 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3CollPlant Names Shomrat Shurtz Senior Director of Business Development 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 4Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 5
... Calif., July 30 Varian, Inc.,(NasdaqGS: VARI) announced ... systems. The TPS-compact provides plug-and-play, hydrocarbon free,ultra-high vacuum ... by a,light (max weight 19.1kg/42.1lbs.) scroll pump., ... powered by,either the Turbo-V 81 MacroTorr(TM) or Turbo-V ...
... Development Of Lead Drug Candidates, MARKHAM, ON, ... of a CDN $45 million Series C financing. ... Tanabe Pharma Corporation ("MTPC"), and supported,by a number ... Inc., Caisse de Depot et Placement du Quebec, ...
... Pharmaceuticals today announced that it has partnered with Green Mountain Energy ... the total calculated carbon dioxide (CO2) emissions thereby enabling them to ... ... Costa Mesa, CA (PRWEB) July 30, 2008 -- Alkemists Pharmaceuticals today ...
Cached Biology Technology:New Turbomolecular Pumping System From Varian, Inc. Delivers Portable, Dry, Ultra-high Vacuum. 2Cytochroma Closes $45 Million Series C Financing 2Cytochroma Closes $45 Million Series C Financing 3Alkemists Sets The Bar, Becoming a 'Green' Analytical Laboratory 2Alkemists Sets The Bar, Becoming a 'Green' Analytical Laboratory 3
(Date:6/29/2015)... , June 24, 2015 ... addition of the "Latin America Biomedical Sensors Market ... their offering. The Latin America Biomedical Sensors ... a CAGR of 2.04% over the period 2014-2020 ... are adaptable to the genetic formulation of each individual. ...
(Date:6/25/2015)... -- TAKE Solutions Ltd., a global business technology solutions provider, ... and Trademark Office (USPTO) for its "Method for Optimizing ... Accelerators to reduce the time taken to standardize trial ... the accelerators), thus reducing time to market. ... heart of the patented Clinical Data Standardization Process are ...
(Date:6/24/2015)... 22, 2015 Research ... of the "Huawei Ascend Mate 7 Fingerprint ... their offering. Huawei,s technological choice for ... direction than Apple,s and Samsung,s one. The Ascend ... by Fingerprint Cards, a main actor in capacitive ...
Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2TAKE Solutions Awarded Patent By USPTO 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2
... to assess the environmental risks posed by pharmaceuticals are ... researcher from the University of Gothenburg (Sweden) who is ... we need to include the combined effects of different ... really is," says Sara Brosch from the Department of ...
... Scientific Program of the 2010 American Academy of ... (MEACO) Joint Meeting includes a report on ... with certain incurable retinal diseases. The AAO-MEACO meetingthe ... session October 16 through 19 at McCormick Place, ...
... A total of 15 world renowned cognitive scientists have been ... the 6th Decade of the Mind Conference to be held ... organised by A*STAR,s Institute of High Performance Computing (IHPC), MINDEF,s ... it is the first such conference in Asia to promote ...
Cached Biology News:Environmental risk assessment of pharmaceuticals inadequate 2Singapore hosts first 'Decade of the Mind' conference in Asia 2Singapore hosts first 'Decade of the Mind' conference in Asia 3
Mouse monoclonal antibody raised against a partial recombinant TTC3. NCBI Entrez Gene ID = TTC3...
Mouse polyclonal antibody raised against a partial recombinant SYT4. NCBI Entrez Gene ID = 6860...
Mouse monoclonal antibody raised against a partial recombinant IL31RA. NCBI Entrez Gene ID = IL31RA...
...
Biology Products: